DBV TECHNOLOGIES Aktie [WKN DE: A1JWB7 / ISIN: FR0010417345]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Historisch	Analysen
Ausblick

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen
Ausblick

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu DBV TECHNOLOGIES

12.08.20		Monthly information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2020 (GlobeNewswire)
04.08.20		DBV Technologies Receives Complete Response Letter from FDA for Viaskin Peanut BLA in Children Ages 4-11 Years (GlobeNewswire)
31.07.20		DBV Technologies Reports First Half 2020 Financial Results (GlobeNewswire)
20.07.20		Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF (GlobeNewswire)
15.07.20		Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2020 (GlobeNewswire)
10.07.20		DBV Technologies Announces Publication of PEOPLE Phase III Open-Label Extension Study Evaluating Viaskin Peanut in The Journal of Allergy and Clinical Immunology (GlobeNewswire)
26.06.20		DBV Technologies Provides Operational and Business Update (GlobeNewswire)
11.06.20		Monthly information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2020 (GlobeNewswire)
04.06.20		DBV Technologies to Present Data on Epicutaneous Immunotherapy and Food Allergy Quality of Life at EAACI Digital Congress 2020 (GlobeNewswire)
02.06.20		DBV Technologies To Present at the Goldman Sachs 41st Annual Global Healthcare Conference (GlobeNewswire)
12.05.20		Information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2020 (GlobeNewswire)
30.04.20		DBV Technologies Reports March 31, 2020 Cash Position (GlobeNewswire)
20.04.20		DBV Technologies Announces Results of its 2020 Ordinary and Extraordinary General Meeting (GlobeNewswire)
15.04.20		Monthly information regarding the total number of voting rights and total number of shares of the Company (GlobeNewswire)
10.04.20		Ordinary and Extraordinary General Meeting of April 20, 2020 to be Held in Closed Virtual Session Due to COVID-19 Pandemic (GlobeNewswire)
30.03.20		Ordinary and Extraordinary General Meeting of April 20, 2020 (GlobeNewswire)
26.03.20		Monthly information regarding the total number of voting rights and total number of shares of the Company (GlobeNewswire)
20.03.20		DBV Technologies Announces Filing of 2019 Universal Registration Document and 2019 Annual Report on Form 20-F (GlobeNewswire)
17.03.20		Monthly information regarding the total number of voting rights and total number of shares of the Company as of February 29, 2020 and March 4, 2020 (GlobeNewswire)
16.03.20		DBV Technologies Provides Update on Viaskin Peanut BLA for Children Ages 4-11 Years (GlobeNewswire)
04.03.20		DBV Technologies Reports Full-Year 2019 Financial Results and Provides Business Update (GlobeNewswire)
04.03.20		DBV Technologies Announces Closing of Underwriters’ Option to Purchase Additional Ordinary Shares in the Form of American Depositary Shares in Connection With its Global Offering (GlobeNewswire)
02.03.20		DBV Technologies Announces Partial Exercise of Underwriters’ Option to Purchase Additional Shares in Connection With its Global Offering of Ordinary Shares in the Form of American Depositary Shares (A (GlobeNewswire)
24.02.20		DBV Technologies to Present Detailed Safety and Efficacy Data of Viaskin Peanut at AAAAI 2020 (GlobeNewswire)
21.02.20		DBV Technologies Announces FDA Advisory Committee Meeting to Review Viaskin Peanut for the Treatment of Peanut Allergy in Children (GlobeNewswire)
10.02.20		DBV Technologies to Present at the SVB Leerink 9th Annual Global Healthcare Conference (GlobeNewswire)
07.02.20		Monthly information regarding the total number of voting rights and total number of shares of the Company as of January 31, 2020 and February 4, 2020 (GlobeNewswire)
06.02.20		DBV Technologies Announces Appointment of Pascal Wotling as Chief Technical Operations Officer (GlobeNewswire)
04.02.20		DBV Technologies Announces Closing of Global Offering (GlobeNewswire)
30.01.20		DBV Technologies Announces Pricing of $153.7 million (€139.8 million) Global Offering of Ordinary Shares, Including in the Form of American Depositary Shares (GlobeNewswire)
29.01.20		DBV Technologies Announces the Launch of a Proposed Global Offering of Ordinary Shares, Which May Be in the Form of American Depositary Shares, and Reports December 31, 2019 Cash Position (GlobeNewswire)
15.01.20		Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF (GlobeNewswire)
14.01.20		Monthly information regarding the total number of voting rights and total number of shares of the Company (GlobeNewswire)
08.01.20		DBV Technologies Reports Positive Three-Year, Long-Term Data from the PEOPLE Phase III Open-Label Extension Study of Viaskin Peanut in Children with Peanut Allergy (GlobeNewswire)
02.01.20		DBV Technologies Announces Appointment of Ramzi Benamar as Chief Financial Officer (GlobeNewswire)
10.12.19		Monthly information regarding the total number of voting rights and total number of shares of the Company (GlobeNewswire)
19.11.19		Monthly information regarding the total number of voting rights and total number of shares of the Company (GlobeNewswire)
05.11.19		DBV Technologies to Present at the Stifel 2019 Healthcare Conference (GlobeNewswire)
24.10.19		DBV Technologies to Highlight the Burden of Peanut Allergy and Patient Experiences with Viaskin Peanut at ACAAI 2019 (GlobeNewswire)
16.10.19		Monthly information regarding the total number of voting rights and total number of shares of the Company (GlobeNewswire)
15.10.19		DBV Technologies Announces Closing of Global Offering (GlobeNewswire)
10.10.19		DBV Technologies Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares in Connection With its Global Offering of Ordinary Shares in the Form of American Depositary Shares (ADSs (GlobeNewswire)
09.10.19		DBV Technologies Announces Pricing of $125 million (€114 million) Global Offering of Ordinary Shares, Including in the Form of American Depositary Shares (GlobeNewswire)
08.10.19		DBV Technologies Announces the Launch of a Proposed Global Offering of Ordinary Shares, Which May Be in the Form of American Depositary Shares, and Reports September 30, 2019 Cash Position (GlobeNewswire)
04.10.19		DBV Technologies Announces FDA Acceptance of BLA filing for Viaskin Peanut for the Treatment of Peanut Allergy (GlobeNewswire)
02.10.19		Monthly information regarding the total number of voting rights and total number of shares of the Company (GlobeNewswire)
19.09.19		Monthly information regarding the total number of voting rights and total number of shares of the Company (GlobeNewswire)
07.08.19		DBV Technologies Submits Biologics License Application to U.S. Food and Drug Administration for Viaskin Peanut for the Treatment of Peanut Allergy (GlobeNewswire)
01.08.19		DBV Technologies Reports First Half 2019 Financial Results (GlobeNewswire)
18.07.19		Amendment to the DBV Technologies Liquidity Contract with NATIXIS ODDO BHF and Half-Year Report (GlobeNewswire)

Zurück | 1 | 2 | 3 | 4 | Weiter

Newssuche

Meistgelesene Nachrichten

Ausblick: OMV legt Zahlen zum jüngsten Quartal vor

BASF-Aktie in Rot: Millionen-Investition in Ludwigshafen

BAWAG-Aktie mit Gewinnen: BAWAG meldet Gewinnsprung für das erste Quartal

Hims & Hers-Aktie im Höhenflug: Deal mit Novo Nordisk bringt frischen Schub

Plug Power-Aktie hebt ab: Vorläufige Ergebnisse und Kreditvereinbarung als Treiber

STRABAG-Aktie zieht kräftig an: STRABAG mit Rekordgewinn

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Wie bewerten Sie diese Seite?

schlecht sehr gut

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2025 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

** Hinweis zu Plus500: 86% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	01.05.2025 12:03
Kaufwert:	EUR
	Hinzufügen Speichern

DBV TECHNOLOGIES Aktie [WKN DE: A1JWB7 / ISIN: FR0010417345]

Nachrichten zu DBV TECHNOLOGIES

Eintrag hinzufügen Eintrag bearbeiten

Newssuche

Meistgelesene Nachrichten